Ikarian Capital »

Cybin Ord shares owned by Ikarian Capital

Quarter-by-quarter ownership of Cybin Ord (CYBN) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Cybin Ord

Tip: Access up to 7 years of quarterly data

All positions including Cybin Ord held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin Ord by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.8M 14M 0.41

More positions owned by Ikarian Capital

Krystal Biotech Put Option (KRYS)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Alnylam Pharmaceuticals (ALNY)
Crinetics Pharmaceuticals In (CRNX)
Sarepta Therapeutics (SRPT)
Corcept Therapeutics Incorporated Put Option (CORT)
Tarsus Pharmaceuticals (TARS)
Disc Medicine (IRON)
Soleno Therapeutics (SLNO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Astrazeneca Sponsored Adr Call Option (AZN)
Bridgebio Pharma (BBIO)
Eyepoint Pharmaceuticals Com New (EYPT)
Biomea Fusion Put Option (BMEA)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Cybin Ord

RA Capital Management
Logos Global Management
Avidity Partners Management
Sphera Funds Management
Octagon Capital Advisors
Rosalind Advisors
Altium Capital Management
Ikarian Capital
Point72 Asset Management
Alyeska Investment Group
AIGH Capital Management
Boothbay Fund Management
AWM Investment Company
AdvisorShares Investments
PDS Planning

View all funds holding Cybin Ord